LAMOTRIGINE
| Brand name | LAMICTAL XR |
|---|---|
| Active ingredient | LAMOTRIGINE |
| Strength | 200MG |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8637512 | January 2029 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.